Synthesis, structures and the biological activity study on the metal complexes of 2-(4-aminophenyl)benzothiazole derivative

[1]  P. K. Basniwal,et al.  2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. , 2006, Mini reviews in medicinal chemistry.

[2]  E. Sausville,et al.  Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells , 2006, Cancer Chemotherapy and Pharmacology.

[3]  Yan Jin,et al.  DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA. , 2005, Journal of the American Chemical Society.

[4]  S. Mallik,et al.  Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groups. , 2005, Chemical communications.

[5]  S. Mallik,et al.  Two-prong inhibitors for human carbonic anhydrase II. , 2004, Journal of the American Chemical Society.

[6]  S. Mallik,et al.  Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. , 2004, Journal of the American Chemical Society.

[7]  A. Monks,et al.  The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human-Derived Breast Carcinoma Xenograft Models , 2004, Breast Cancer Research and Treatment.

[8]  Ning Gan,et al.  Oxidative DNA strand scission induced by a trinuclear copper(II) complex. , 2004, Inorganic chemistry.

[9]  A. Westwell,et al.  The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. , 2004, Current medicinal chemistry.

[10]  G. Neelakanta,et al.  Oxidative cleavage of DNA by a dipyridoquinoxaline copper(II) complex in the presence of ascorbic acid. , 2002, Journal of inorganic biochemistry.

[11]  M. Stevens,et al.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. , 2002, Journal of medicinal chemistry.

[12]  M. E. Branum,et al.  Double-strand DNA hydrolysis by dilanthanide complexes , 1999, JBIC Journal of Biological Inorganic Chemistry.

[13]  E. Sausville,et al.  Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles. , 1999, Journal of medicinal chemistry.

[14]  Maria Cristina Burla,et al.  SIR97: a new tool for crystal structure determination and refinement , 1999 .

[15]  K. Paull,et al.  2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. , 1998, British Journal of Cancer.

[16]  D. Davies,et al.  Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. , 1994, Journal of medicinal chemistry.

[17]  D. Crothers,et al.  The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Yates,et al.  Structural studies on benzothiazoles. Crystal and molecular structure of 5,6-dimethoxy-2-(4-methoxyphenyl-benzothiazole and molecular orbital calculations on related compounds. , 1991 .

[19]  L. Povirk,et al.  DNA double-strand breaks and alkali-labile bonds produced by bleomycin. , 1977, Nucleic acids research.

[20]  J. Lepecq,et al.  A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. , 1967, Journal of molecular biology.

[21]  M. Waring,et al.  Complex formation between ethidium bromide and nucleic acids. , 1965, Journal of molecular biology.

[22]  J. Marmur.  A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .

[23]  S. Rice,et al.  A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid , 1954 .